SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jul 30, 2026

ATRC

AtriCure, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $1.2M total
Actionable Insight • Neutral

The insider sales are negligible in size and follow a strong earnings beat, suggesting profit-taking rather than informed selling. No bearish read-through; monitor for any larger or accelerating insider sales in coming weeks.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$37.76
T+0 close · Jul 30, 2026 · via day close
Latest settled
+61.76%
T+60 · $61.08
Vs SPY
+59.30%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 31 $37.76entry
  2. T+1 · 4mo ago +2.54%α +1.12% · $38.72
  3. T+5 · 3mo ago +9.61%α +6.10% · $41.39
  4. T+20 · 3mo ago +28.55%α +25.56% · $48.54
  5. T+60 · 22d ago +61.76%α +59.30% · $61.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three AtriCure insiders (Director, CSO, CMO) sold a total of $1.42M in open-market shares over two days following a strong Q2 earnings beat. The sales represent only ~0.07% of market cap and are likely routine profit-taking after the stock's post-earnings run, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
3

Key Facts

  • Director Sven Wehrwein sold 25,000 shares at $37.84 for $946K on 2026-07-28, also exercised derivatives (non-cash).
  • CSO Vinayak Doraiswamy sold 6,000 shares at $38.88 for $233K on 2026-07-28.
  • CMO Justin Noznesky sold 6,182 shares at $38.80 for $240K on 2026-07-29.
  • Total open-market sales: $1.42M, or ~0.07% of ATRC's $2.1B market cap.
  • Sales occurred 5-6 days after a bullish Q2 2026 earnings release (EPS $0.18 vs $0.03 consensus, revenue +12.8% YoY, raised guidance).

Financial Impact

Insider sales of $1.42M are trivial relative to $2.1B market cap; no material financial impact.

Risk Factors

  • If additional insiders begin selling larger positions, sentiment could shift.
  • Post-earnings profit-taking could cap near-term upside if selling pressure continues.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
81% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ATRC-1785481452676

US Market Status

Market Closed · Opens in 7h 3m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 31, 2026